Inventor · disambiguated record
Zhiqi Qi
Also filed as: QI ZHIQI
7 granted patents·4 pending applications·8 citations·filing 2013–2020
71Inventor score
Top patents by PatentIndex Score
11 records- 0186US9815846B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Nov 14, 2017·8 cites·16 claims
- 0269US2021040096A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 0362US2019322666A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 0458US2018099967A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 0554US2017190701A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsYU TAO·Filed 2016·Application pending·0 cites
- 0651US9981969B2Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2014·Granted May 29, 2018·0 cites·5 claims
- 0750US9975888B2Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2014·Granted May 22, 2018·0 cites·17 claims
- 0849US10745377B2Piperidine or piperazine linked imidazole and triazole derivatives and methods of useMERCK SHARP & DOHME·Filed 2014·Granted Aug 18, 2020·0 cites·8 claims
- 0945US9556202B2Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·0 cites·20 claims
- 1040US10556900B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2016·Granted Feb 11, 2020·0 cites·11 claims
- 1140US9862707B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Zhiqi Qi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →